For example, tocilizumab can target inhibit IL-6 in order to prevent the increased of IL-6 and stop related toxicities (108); patients with high titer of TgAbs and TPOAbs who developed to grade 2 hypothyroidisms early take a moderate dosage of L-T4 therapy throughout (43). The gene discussed is IL6; the disease is hypothyroidism.